MACROGENICS INC — Director's Dealing 2020

Sep 10, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MACROGENICS INC (MGNX)
CIK: 0001125345
Period of Report: 2020-09-09

Reporting Person: Galbraith Kenneth (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-09-09	Common Stock	M	13849	$16	Acquired	13849	Direct
2020-09-09	Common Stock	S	13849	$27.11	Disposed	0	Direct
2020-09-09	Common Stock	M	6924	$20.15	Acquired	6924	Direct
2020-09-09	Common Stock	S	6924	$27.11	Disposed	0	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-09-09	Stock Option (right to buy)	$16.0	M	13849	Disposed	2023-10-09	Common Stock (13849.0)	Direct
2020-09-09	Stock Option (right to buy)	$20.15	M	6924	Disposed	2024-06-05	Common Stock (6924.0)	Direct

Footnotes

F1: This transaction was executed in multiple trades at prices ranging from $26.96 to $27.22. The reporting person undertakes to provide to MacroGenics, Inc., any security holder of MacroGenics, Inc., or the staffof the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

F2: 33.33% of the option became exercisable on October 9, 2014, and the remainder of the option vested in substantially equal annual installments.

F3: The option vested and became exercisable in monthly, cumulative 1/12th increments (rounded upwards to whole shares) beginning one month from the date of grant.